Technology Transactions, Licensing and Commercialization
We help companies build core business relationships that turn innovation into commercial success by structuring and implementing technology transactions, licensing arrangements, and strategic collaborations that protect intellectual property, accelerate commercialization, and create long-term value.


Summary
Procopio helps companies build the strategic relationships that turn innovation into commercial success. Whether working with customers, suppliers, manufacturers, distributors, research institutions, strategic partners, or investors, businesses rely on carefully structured agreements to commercialize innovation, protect intellectual property, allocate risk, and support long-term growth.
Innovation often reaches the market through collaboration. We advise clients on the technology transactions, licensing arrangements, and commercial agreements that support every stage of the innovation lifecycle, including joint development, research collaborations, software and SaaS, manufacturing and supply, distribution, data rights, strategic alliances, and intellectual property licensing. Whether acquiring technology, commercializing it, or creating new business partnerships, we help clients structure practical agreements that advance their business objectives.
Our multidisciplinary team works closely with attorneys across the firm’s corporate, intellectual property, privacy, tax, employment, regulatory, and litigation practices to address the legal and business issues that accompany complex commercial relationships. This integrated approach allows us to align individual transactions with broader business strategy while helping clients anticipate challenges and negotiate from a position of strength.
We represent companies across industries including life sciences, healthcare, software, artificial intelligence, manufacturing, consumer products, digital commerce, and emerging technologies. From startups commercializing their first innovation to established companies negotiating global collaborations, we help clients create partnerships that support growth, strengthen competitive advantage, and build long-term enterprise value.
Strategic Collaborations and Business Partnerships
Structuring collaborations that allow organizations to develop, commercialize, manufacture, and distribute innovative products and services.
- Joint development agreements
- Research collaborations
- Strategic alliances
- Co-branding agreements
- Joint ventures
- Commercialization partnerships
- Distribution agreements
- Reseller agreements
Commercialization and Intellectual Property Licensing
Helping clients bring innovation to market through licensing and commercialization strategies that maximize the value of intellectual property.
- Inbound and outbound IP licensing
- Technology transfer agreements
- Trademark and copyright licensing
- Patent licensing
- University and research institution licensing
- Material transfer agreements
- Know-how and data licensing
- Joint Development Agreements
- Consulting Agreements
Software, Data, and Digital Transactions
Supporting companies that develop, license, and commercialize software, AI, digital platforms, and data-driven products.
- SaaS agreements
- Software licensing
- Cloud services agreements
- API and platform agreements
- Data licensing
- Data privacy and data sharing agreements
- Technology services agreements
Supply Chain, Manufacturing, and Commercial Agreements
Helping companies build the operational partnerships needed to produce and deliver products.
- Manufacturing agreements
- Supply agreements
- Distribution arrangements
- Outsourcing agreements
- Vendor agreements
- Procurement agreements
- Consulting Agreements
Strategic Transactions and Intellectual Property Due Diligence
Advising companies as technology and intellectual property become part of broader business transactions.
- Technology due diligence
- IP due diligence
- Technology acquisitions
- Technology divestitures
- Collaboration support during M&A
- Transaction support for financings
- IP portfolio evaluation
Strategic Collaborations and Commercialization
- Negotiated and structured a cross-license and collaboration agreement between a global pharmaceutical company and a life sciences diagnostics company supporting development, clinical trials, FDA approval, and future commercialization of a companion diagnostic and therapeutic.
- Structured legal relationships for a nonprofit research organization and major hospital system to facilitate preclinical and clinical research, including licensing, material transfer, clinical trial, and third-party services agreements.
- Represented biotechnology companies in inbound and outbound licensing of intellectual property supporting commercialization of new technologies.
- Negotiated strategic collaboration, development, and commercialization agreements for life sciences, healthcare, and technology companies.
Software, Technology, and Digital Commerce
- Negotiated enterprise software license and consulting services agreements between a data analytics company and Fortune 100 and Fortune 500 customers.
- Negotiated software licensing, SaaS, reseller, payment network, technology services, and platform agreements for software and financial technology companies.
- Advised companies on e-commerce terms and conditions, privacy policies, technology services agreements, and proprietary information protections.
- Negotiated software, intellectual property, hardware, and customization agreements for a large healthcare organization and a Fortune 50 technology company.
Manufacturing, Supply Chain, and Global Commercial Agreements
- Negotiated international trademark and technology licensing arrangements supporting offshore manufacturing and distribution of health and wellness products in Asia.
- Negotiated trademark and copyright licensing agreements for the manufacture, marketing, and distribution of globally recognized consumer products.
- Negotiated complex commercial supply agreements supporting commercialization of late-stage life sciences products.
- Advised companies on manufacturing, supply, distribution, outsourcing, and import/export arrangements across multiple industries.
Transactions Involving Innovation and Intellectual Property
- Conducted technology and intellectual property due diligence for venture financings, strategic investments, mergers and acquisitions, and public offerings involving life sciences, medical device, digital health, and software companies.
- Represented pharmaceutical, medical device, and technology companies in acquisitions involving complex intellectual property portfolios, licensing arrangements, manufacturing agreements, and royalty structures.
- Advised public and private companies on strategic partnerships, technology acquisitions, and commercialization transactions supporting business growth.
We have a new technology or product. When should we involve a technology transactions attorney?
Earlier than many companies expect. Decisions made during product development, customer pilots, research collaborations, and early commercial discussions can affect future licensing opportunities, intellectual property rights, revenue models, and investment value. Involving counsel early often helps companies avoid having to renegotiate key business relationships later.
We’re exploring a strategic partnership. How can we protect our interests without slowing down the deal?
The best agreements create clarity rather than obstacles. We work with clients to identify the issues that matter most, including ownership of intellectual property, confidentiality, commercialization rights, financial terms, performance obligations, and future business opportunities. Our goal is to help clients move transactions forward while protecting the assets that make the partnership valuable.
We’re not ready to license our technology yet. Can you still help?
Absolutely. Many clients engage us well before a licensing opportunity exists. We help companies build the legal foundation for future commercialization by structuring early collaborations, protecting intellectual property, negotiating development and commercial agreements, and preparing for future partnerships, investment, or licensing discussions.
How do we know whether to license our technology, commercialize it ourselves, or pursue a strategic partnership?
The answer depends on your business goals, available resources, intellectual property, financing, market opportunities, and long-term strategy. We help clients evaluate different commercialization models and structure legal arrangements that align with their business objectives, whether that means licensing, co-development, strategic alliances, manufacturing relationships, distribution arrangements, or direct commercialization.
How do technology transactions fit with intellectual property, corporate, and regulatory issues?
Technology transactions rarely exist in isolation. A licensing agreement may involve corporate governance, privacy, employment, tax, regulatory compliance, intellectual property, or future financing considerations. Our attorneys work across disciplines to help ensure individual transactions support broader business objectives and long-term growth.
We already have outside counsel. When should we consider expanding or changing our legal team?
Companies often outgrow legal relationships that began with company formation or intellectual property protection alone. As commercialization efforts become more sophisticated through strategic partnerships, international expansion, acquisitions, licensing, or complex commercial agreements, many organizations benefit from a multidisciplinary legal team that can coordinate legal strategy across multiple practice areas while working closely with management and existing advisors.
14 results found.
China Licensing to Save Lives Worldwide
30 Procopio Attorneys Named 2020 Best Lawyers in America
Promoting your best interests
We’ve trusted Procopio
Familiarity with startups and life sciences














































